A Cloud Security Alliance study published June 2 draws a direct line between delayed patching and confirmed security incidents: organizations that fail to apply patches within 24 hours of release report breaches at an 80% rate when a known vulnerability is involved. The finding arrives as healthcare organizations face mounting pressure to maintain current patch cycles across increasingly complex environments that now include AI-assisted clinical tools.

The 24-hour window problem

The CSA data reinforces what breach investigators have long documented — unpatched known vulnerabilities remain among the most reliable entry points for threat actors, precisely because the exploitation timeline has shortened dramatically since public disclosure became routine. For independent practices and small health systems, the challenge is structural: many lack dedicated security staff whose primary responsibility is monitoring vendor patch releases and coordinating deployment across clinical and administrative systems simultaneously.

The 80% figure is notable because it concerns known vulnerabilities — flaws for which patches already exist at the time of exploitation. That distinguishes this category of incident from zero-day attacks, where defenders have no advance warning. Missing a 24-hour window on a known flaw is, in effect, a process failure rather than a knowledge failure.

AI runtime visibility is the emerging gap

The study also found that 82% of organizations have no real-time visibility into AI runtime behavior — meaning they cannot observe what AI systems are doing once deployed in production environments. Pre-production testing controls, which have historically served as a checkpoint for catching flawed code before it reaches live systems, are not closing that gap in AI-enabled environments.

For healthcare settings where AI tools are being integrated into clinical decision support, scheduling, prior authorization workflows, and ambient documentation, this blind spot carries specific risk. An AI component with an unmonitored runtime could interact with protected health information in ways that were not anticipated during testing, and without runtime telemetry, that activity would go undetected until after a reportable incident.

The absence of runtime monitoring also complicates incident response. Determining the scope of a breach — a requirement under HIPAA's breach notification rule — becomes significantly harder when an organization cannot reconstruct what an AI system accessed or transmitted during the window of a potential compromise.

What this means for patch and monitoring programs

Practices operating without a formal patch management schedule should treat the CSA data as a baseline benchmark against which to measure their own exposure. Several practical questions follow from the findings:

• Patch inventory and prioritization. Does the practice maintain a current inventory of all software, firmware, and cloud-connected tools, with vendor patch release feeds monitored for each? Prioritization frameworks that rank patches by exploitability and asset sensitivity — rather than applying them in the order received — reduce the risk that a critical flaw sits unaddressed while lower-priority updates are processed.
• Deployment timelines by asset class. Internet-facing systems, remote access infrastructure, and systems handling electronic protected health information warrant the shortest deployment windows. A 24-hour target is operationally aggressive for many small practices; a tiered policy that sets explicit deadlines by risk category is more achievable than a single blanket target.
• AI system monitoring. Organizations that have deployed AI tools — whether built into an EHR, acquired as a standalone module, or integrated via API — should confirm with vendors whether runtime logging is available and whether that log data is being retained and reviewed. Contractual language in business associate agreements should address what AI runtime data the vendor collects, retains, and makes available for audit purposes.

What the next review cycle should address

The CSA findings arrive as HHS continues deliberating updates to the HIPAA Security Rule, with proposed changes that would establish more prescriptive requirements around vulnerability management and risk analysis documentation. Organizations that can demonstrate a documented, tested patch management process with defined timelines and exception tracking will be better positioned when those requirements take effect — and better positioned to avoid the category of incidents the CSA study describes.

The AI runtime visibility gap is likely to draw increasing regulatory attention as clinical AI adoption accelerates. Practices that establish monitoring and logging requirements for AI tools now, before formal guidance solidifies, will have more data available to demonstrate compliance and to support breach investigation if one occurs.